東方通(300379.SZ)擬斥1億元設立全資子公司 打造獨立基礎軟件產業體系
格隆匯2月6日丨東方通(300379.SZ)公佈,為了實現公司董事會制定的整體發展戰略,優化公司集團化業務管控結構,打造獨立的基礎軟件產業體系,公司擬使用自有資金1億元人民幣投資設立全資子公司——北京東方通軟件有限公司(暫定名,以工商行政管理部門核准的名稱為準)。
北京東方通軟件有限公司(暫定名,以工商行政管理部門核准的名稱為準)經營範圍:技術推廣;軟件服務;銷售計算機、軟件及輔助設備;計算機系統服務;信息系統集成服務。(企業依法自主選擇經營項目,開展經營活動;依法須經批准的項目,經相關部門批准後依批准的內容開展經營活動;不得從事本市產業政策禁止和限制類項目的經營活動。)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.